CareDx, Inc. (NASDAQ:CDNA) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ET

Company Participants

Greg Chodaczek - Managing Director
John Hanna - President and CEO
Abhishek Jain - Chief Financial Officer
Robert Woodward - Chief Scientific Officer
Alex Johnson - President, Patient and Testing Services

Conference Call Participants

Bill Bonello - Craig-Hallum
Kayla Hostetler - Jefferies
Prashant Kota - Goldman Sachs
Andrew Cooper - Raymond James
Nathan Kariko - Stephens
Vivian Bais - BTIG
Yi Chen - H.C. Wainwright
Thomas DeBourcy - Nephron Research

Operator

Good day, everyone. And welcome to today’s CareDx Incorporated Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question-and-answer session. [Operator Instructions]

Please note this call may be recorded. I’ll be standing by if you should need any assistance. It is now my pleasure to turn the call over to Mr. Greg Chodaczek, Managing Director.

Greg Chodaczek

Thanks, Leo. Good afternoon and thank you for joining us today. Earlier today, CareDx released financial results for the quarter ending June 30, 2024. The release is currently available on the company’s website at www.caredx.com.

John Hanna, President and Chief Executive Officer; and Abhishek Jain, Chief Financial Officer, will host this afternoon’s call.

Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements within the meaning of the federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.

Any statements contained in this call that are not statements of historical facts should be deemed to be forward-looking statements. All forward-looking statements, including without limitation, are examination of historical operating trends, expectations regarding coverage decisions, pricing and enrollment matters, and our financial expectations and results are based upon current estimates and various assumptions.

These statements involve material risks and uncertainty, so that could cause actual results to differ materially from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements. For a list and description of the risks and uncertainties associated with our business, please see our filings with the Securities and Exchange Commission.

The information provided in this conference call speaks only to the live broadcast today, July 31, 2024. CareDx disclaims any intention or obligation except as required by law to update or revise any information, financial projections, or other forward-looking statements, whether because of new information, future events, or otherwise.